IASIC Speaker Series
The International Academy on the Science and Impact of Cannabis (IASIC) is excited to present the IASIC Speaker Series. Presented free of charge, this ongoing educational seminar series will focus on the science, data, and peer-reviewed research surrounding marijuana and will be led by international medical experts. This non-partisan and non-political series is continually developed, organized, and guided by doctors.
Upcoming Seminars
Increasing breast and testis cancer in young adults: Cannabis-cancer connection?
Monday, July 21st @ 1:00 p.m. Eastern
Join us for the next IASIC Speakers Series with Dr. Archie Bleyer—renowned clinical researcher and cancer epidemiologist—who will present findings from his recent study, "Increasing Breast and Testis Cancer in Young Adults: Cannabis-Cancer Connection." Drawing on decades of clinical expertise and the latest data, Dr. Bleyer will explore the biological plausibility, epidemiological patterns, and public health implications of this connection. Join us for a critical conversation at the intersection of youth health, cannabis policy, and cancer prevention.
Speaker: Archie Bleyer, MD
About the Speaker: Dr. Bleyer is a globally recognized leader in cancer research and public health with over five decades of experience advancing clinical science.
He serves as Clinical Research Professor in Radiation Medicine and the Knight Cancer Institute at Oregon Health & Science University, Professor of Pediatrics at McGovern Medical School at the University of Texas, and a collaborator with the Institute for Health Metrics and Evaluation at the University of Washington.
Dr. Bleyer has authored more than 330 peer-reviewed publications and has led research supported by over $85 million in grants. He is the editor of the landmark textbook Cancer in Adolescents and Young Adults, featuring 129 expert contributors from 11 countries.
A compelling voice in drug policy research, he presented “The Ugly: Marijuana Legalization → Deaths & Opioid Deaths” at the 2023 National Interdisciplinary Cannabis Symposium and co-authored a pivotal 2022 study in the Journal of the National Medical Association linking marijuana legalization trends to opioid mortality.